Evidence map›Paper›PMID 32952940›Full record

ArticleComputational and structural biotechnology journal2020

UMI-Gen: A UMI-based read simulator for variant calling evaluation in paired-end sequencing NGS libraries.

Vincent Sater, Pierre-Julien Viailly, Thierry Lecroq, Philippe Ruminy, Caroline Bérard, Élise Prieur-Gaston, Fabrice Jardin

Open access · goldAbstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Cloud-native distributed genomic pileup operations.Bioinformatics (Oxford, England) · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vincent SaterUniversity of Rouen Normandy UNIROUEN, LITIS EA 4108, 76000 Rouen, France.
Pierre-Julien ViaillyDepartment of Pathology, Centre Henri Becquerel, 76000 Rouen, France.
Thierry LecroqUniversity of Rouen Normandy UNIROUEN, LITIS EA 4108, 76000 Rouen, France.
Philippe RuminyDepartment of Pathology, Centre Henri Becquerel, 76000 Rouen, France.
Caroline BérardUniversity of Rouen Normandy UNIROUEN, LITIS EA 4108, 76000 Rouen, France.
Élise Prieur-GastonUniversity of Rouen Normandy UNIROUEN, LITIS EA 4108, 76000 Rouen, France.
Fabrice JardinDepartment of Pathology, Centre Henri Becquerel, 76000 Rouen, France.
Inserm · FRLaboratoire d'Informatique, du Traitement de l'Information et des Systèmes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationWith Next Generation Sequencing becoming more affordable every year, NGS technologies asserted themselves as the fastest and most reliable way to detect Single Nucleotide Variants (SNV) and Copy Number Variations (CNV) in cancer patients. These technologies can be used to sequence DNA at very high depths thus allowing to detect abnormalities in tumor cells with very low frequencies. Multiple variant callers are publicly available and are usually efficient at calling out variants. However, when frequencies begin to drop under 1%, the specificity of these tools suffers greatly as true variants at very low frequencies can be easily confused with sequencing or PCR artifacts. The recent use of Unique Molecular Identifiers (UMI) in NGS experiments has offered a way to accurately separate true variants from artifacts. UMI-based variant callers are slowly replacing raw-read based variant callers as the standard method for an accurate detection of variants at very low frequencies. However, benchmarking done in the tools publication are usually realized on real biological data in which real variants are not known, making it difficult to assess their accuracy.

resultsWe present UMI-Gen, a UMI-based read simulator for targeted sequencing paired-end data. UMI-Gen generates reference reads covering the targeted regions at a user customizable depth. After that, using a number of control files, it estimates the background error rate at each position and then modifies the generated reads to mimic real biological data. Finally, it will insert real variants in the reads from a list provided by the user. AVAILABILITY: The entire pipeline is available at https://gitlab.com/vincent-sater/umigen under MIT license.

Indexed as

NGSSequence analysisSimulatorUMIVariant calling

Identifiers

PMID32952940
PMCPMC7484502
OpenAlexW3082037286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.